{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:04:25Z","timestamp":1794852265858,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81601410"],"award-info":[{"award-number":["81601410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81671606"],"award-info":[{"award-number":["81671606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["82071834"],"award-info":[{"award-number":["82071834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012467","name":"distinguished professor of liaoning province","doi-asserted-by":"publisher","award":["Liao taught 2018 to 2020"],"award-info":[{"award-number":["Liao taught 2018 to 2020"]}],"id":[{"id":"10.13039\/501100012467","id-type":"DOI","asserted-by":"publisher"}]},{"name":"dalian key laboratory of human homeostasis microbiology and disease immunology"},{"DOI":"10.13039\/501100005047","name":"natural science foundation of liaoning province","doi-asserted-by":"publisher","award":["2020-BS-191"],"award-info":[{"award-number":["2020-BS-191"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"natural science foundation of liaoning provincial department education","award":["LZ2020051"],"award-info":[{"award-number":["LZ2020051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic lupus erythematosus (SLE) is characterized by loss of immune tolerance and imbalance of immune cell subsets. Natural killer (NK) cells contribute\u00a0to regulate both the innate and adaptive immune response. In this study, we aimed to detect alterations of peripheral NK cells and explore intrinsic mechanisms involving in NK cell abnormality in SLE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Blood samples from healthy controls (HCs) and patients with SLE and rheumatoid arthritis (RA) were collected. The NK count, NK subsets (CD56<jats:sup>bright<\/jats:sup>, CD56<jats:sup>dim<\/jats:sup>CD57<jats:sup>\u2212<\/jats:sup>, and CD56<jats:sup>dim<\/jats:sup>CD57<jats:sup>+<\/jats:sup>), phenotypes, and apoptosis were evaluated with flow cytometer. Mitochondrial reactive oxygen species (mtROS) and total ROS levels were detected with MitoSOX Red and DCFH-DA staining respectively. Published data (GSE63829 and GSE23695) from Gene Expression Omnibus (GEO) was analyzed by Gene Set Enrichment Analysis (GSEA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Total peripheral NK count was down-regulated in untreated SLE patients in comparison to that in untreated RA patients and HCs. SLE patients exhibited a selective reduction in peripheral CD56<jats:sup>dim<\/jats:sup>CD57<jats:sup>+<\/jats:sup> NK cell proportion, which was negatively associated with disease activity and positively correlated with levels of complement(C)3 and C4. Compared with HCs, peripheral CD56<jats:sup>dim<\/jats:sup>CD57<jats:sup>+<\/jats:sup> NK cells from SLE patients exhibited altered phenotypes, increased endogenous apoptosis and higher levels of mtROS and ROS. In addition, when treated with hydrogen peroxide (H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>), peripheral CD56<jats:sup>dim<\/jats:sup>CD57<jats:sup>+<\/jats:sup> NK cell subset was more prone to undergo apoptosis than CD56<jats:sup>dim<\/jats:sup>CD57<jats:sup>\u2212<\/jats:sup> NK cells. Furthermore, this NK cell subset from SLE patients exhibited impaired cytotoxicity in response to activated CD4<jats:sup>+<\/jats:sup> T cells in\u00a0vitro.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study demonstrated a selective loss of mature CD56<jats:sup>dim<\/jats:sup>CD57<jats:sup>+<\/jats:sup> NK cell subset in SLE patients, which may caused by preferential apoptosis of this subset under increased oxidative stress in SLE. The attenuated in\u00a0vitro cytotoxicity of CD56<jats:sup>dim<\/jats:sup>CD57<jats:sup>+<\/jats:sup> NK cells may contribute to the impaired ability of eliminating pathogenic CD4<jats:sup>+<\/jats:sup> T cells in SLE.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02731-y","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T10:02:39Z","timestamp":1645005759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhimin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziran","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"2","key":"2731_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11926-020-00978-5","volume":"23","author":"PM Chen","year":"2021","unstructured":"Chen PM, Tsokos GC. T Cell Abnormalities in the Pathogenesis of Systemic Lupus Erythematosus: an Update. Curr Rheumatol Rep. 2021;23(2):12. https:\/\/doi.org\/10.1007\/s11926-020-00978-5 PMID: 33512577.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"2731_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/rheumatology\/keaa478.PMID:33099651;PMCID:PMC7785308","volume":"60","author":"JM Pego-Reigosa","year":"2021","unstructured":"Pego-Reigosa JM, Nicholson L, Pooley N, Langham S, Embleton N, Marjenberg Z, Barut V, Desta B, Wang X, Langham J, Hammond ER. The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis. Rheumatology (Oxford). 2021;60(1):60\u201372. https:\/\/doi.org\/10.1093\/rheumatology\/keaa478.PMID:33099651;PMCID:PMC7785308.","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"2731_CR3","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1016\/j.celrep.2018.08.075.PMID:30257198;PMCID:PMC6192537","volume":"24","author":"CE Rydyznski","year":"2018","unstructured":"Rydyznski CE, Cranert SA, Zhou JQ, Xu H, Kleinstein SH, Singh H, Waggoner SN. Affinity Maturation Is Impaired by Natural Killer Cell Suppression of Germinal Centers. Cell Rep. 2018;24(13):3367-3373.e4. https:\/\/doi.org\/10.1016\/j.celrep.2018.08.075.PMID:30257198;PMCID:PMC6192537.","journal-title":"Cell Rep"},{"issue":"1","key":"2731_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.it.2014.11.001","volume":"36","author":"J Crouse","year":"2015","unstructured":"Crouse J, Xu HC, Lang PA, Oxenius A. NK cells regulating T cell responses: mechanisms and outcome. Trends Immunol. 2015;36(1):49\u201358. https:\/\/doi.org\/10.1016\/j.it.2014.11.001 PMID: 25432489.","journal-title":"Trends Immunol"},{"issue":"4","key":"2731_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","volume":"180","author":"P Dogra","year":"2020","unstructured":"Dogra P, Rancan C, Ma W, Toth M, Senda T, Carpenter DJ, Kubota M, Matsumoto R, Thapa P, Szabo PA, Li Poon MM, Li J, Arakawa-Hoyt J, Shen Y, Fong L, Lanier LL, Farber DL. Tissue Determinants of Human NK Cell Development, Function, and Residence. Cell. 2020;180(4):749-763.e13. https:\/\/doi.org\/10.1016\/j.cell.2020.01.022 Epub 2020 Feb 13. PMID: 32059780; PMCID: PMC7194029.","journal-title":"Cell."},{"issue":"19","key":"2731_CR6","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","volume":"116","author":"S Lopez-Verg\u00e8s","year":"2010","unstructured":"Lopez-Verg\u00e8s S, Milush JM, Pandey S, York VA, Arakawa-Hoyt J, Pircher H, Norris PJ, Nixon DF, Lanier LL. CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. Blood. 2010;116(19):3865\u201374. https:\/\/doi.org\/10.1182\/blood-2010-04-282301 Epub 2010 Aug 23. PMID: 20733159; PMCID: PMC2981540.","journal-title":"Blood."},{"issue":"1\u20132","key":"2731_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cell.2018.11.045","volume":"176","author":"PL Collins","year":"2019","unstructured":"Collins PL, Cella M, Porter SI, Li S, Gurewitz GL, Hong HS, Johnson RP, Oltz EM, Colonna M. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176(1\u20132):348-360.e12. https:\/\/doi.org\/10.1016\/j.cell.2018.11.045 Epub 2018 Dec 27. PMID: 30595449; PMCID: PMC6329660.","journal-title":"Cell."},{"issue":"1","key":"2731_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.177.1.155.PMID:8418197;PMCID:PMC2190856","volume":"177","author":"K Takeda","year":"1993","unstructured":"Takeda K, Dennert G. The development of autoimmunity in C57BL\/6 lpr mice correlates with the disappearance of natural killer type 1-positive cells: evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms. J Exp Med. 1993;177(1):155\u201364. https:\/\/doi.org\/10.1084\/jem.177.1.155.PMID:8418197;PMCID:PMC2190856.","journal-title":"J Exp Med"},{"issue":"3","key":"2731_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau R, Hong S, Cantarel B, Baldwin N, Baisch J, Edens M, Cepika AM, Acs P, Turner J, Anguiano E, Vinod P, Kahn S, Obermoser G, Blankenship D, Wakeland E, Nassi L, Gotte A, Punaro M, Liu YJ, Banchereau J, Rossello-Urgell J, Wright T, Pascual V. Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell. 2016;165(3):551\u201365. https:\/\/doi.org\/10.1016\/j.cell.2016.03.008 Epub 2016 Mar 31.","journal-title":"Cell"},{"issue":"4","key":"2731_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","volume":"98","author":"R Spada","year":"2015","unstructured":"Spada R, Rojas JM, Barber DF. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol. 2015;98(4):479\u201387.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2731_CR11","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/art.30313","volume":"63","author":"B Hervier","year":"2011","unstructured":"Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P, et al. Phenotype and Function of Natural Killer Cells in Systemic Lupus Erythematosus. Arthritis Rheum. 2011;63(6):1698\u2013706.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2731_CR12","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.4049\/jimmunol.1000569","volume":"186","author":"Z Huang","year":"2011","unstructured":"Huang Z, Fu B, Zheng SG, Li X, Sun R, Tian Z, et al. Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus. J Immunol. 2011;186(6):3421\u201331.","journal-title":"J Immunol"},{"issue":"9","key":"2731_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. https:\/\/doi.org\/10.1002\/art.1780400928 PMID: 9324032.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2731_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2731_CR15","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288\u201391 PMID: 11838846.","journal-title":"J Rheumatol"},{"issue":"2","key":"2731_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1137\/18m1216134","volume":"1","author":"GC Linderman","year":"2019","unstructured":"Linderman GC, Steinerberger S. Clustering with t-SNE, provably. SIAM J Math Data Sci. 2019;1(2):313\u201332. https:\/\/doi.org\/10.1137\/18m1216134 Epub 2019 May 28. PMID: 33073204; PMCID: PMC7561036.","journal-title":"SIAM J Math Data Sci."},{"issue":"5","key":"2731_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118 Epub 2012 Mar 28. PMID: 22455463; PMCID: PMC3339379.","journal-title":"OMICS."},{"issue":"3","key":"2731_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nri3158.Erratum.In:NatRevImmunol.2012Jun;12(6):471.PMID:22343568;PMCID:PMC3409649","volume":"12","author":"HT Maecker","year":"2012","unstructured":"Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol. 2012;12(3):191\u2013200. https:\/\/doi.org\/10.1038\/nri3158.Erratum.In:NatRevImmunol.2012Jun;12(6):471.PMID:22343568;PMCID:PMC3409649.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2731_CR19","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4049\/jimmunol.1402673","volume":"194","author":"EN Voynova","year":"2015","unstructured":"Voynova EN, Skinner J, Bolland S. Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus. J Immunol. 2015;194(4):1503\u201313. https:\/\/doi.org\/10.4049\/jimmunol.1402673 Epub 2015 Jan 16. PMID: 25595787; PMCID: PMC4323852.","journal-title":"J Immunol."},{"issue":"7","key":"2731_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363\u201383. https:\/\/doi.org\/10.1038\/s41580-020-0230-3 Epub 2020 Mar 30 PMID: 32231263.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"2731_CR21","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.4049\/jimmunol.170.7.3572","volume":"170","author":"BA Rabinovich","year":"2003","unstructured":"Rabinovich BA, Li J, Shannon J, Hurren R, Chalupny J, Cosman D, Miller RG. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J Immunol. 2003;170(7):3572\u20136. https:\/\/doi.org\/10.4049\/jimmunol.170.7.3572 PMID: 12646619.","journal-title":"J Immunol"},{"issue":"12","key":"2731_CR22","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1084\/jem.20080840","volume":"205","author":"JM Odegard","year":"2008","unstructured":"Odegard JM, Marks BR, DiPlacido LD, Poholek AC, Kono DH, Dong C, Flavell RA, Craft J. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med. 2008;205(12):2873\u201386. https:\/\/doi.org\/10.1084\/jem.20080840 Epub 2008 Nov 3. PMID: 18981236; PMCID: PMC2585848.","journal-title":"J Exp Med."},{"issue":"7381","key":"2731_CR23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature10624.PMID:22101430;PMCID:PMC3539796","volume":"481","author":"SN Waggoner","year":"2011","unstructured":"Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature. 2011;481(7381):394\u20138. https:\/\/doi.org\/10.1038\/nature10624.PMID:22101430;PMCID:PMC3539796.","journal-title":"Nature"},{"issue":"4","key":"2731_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/ar4232.PMID:23856014;PMCID:PMC3979027","volume":"15","author":"LA Fogel","year":"2013","unstructured":"Fogel LA, Yokoyama WM, French AR. Natural killer cells in human autoimmune disorders. Arthritis Res Ther. 2013;15(4):216. https:\/\/doi.org\/10.1186\/ar4232.PMID:23856014;PMCID:PMC3979027.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2731_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","volume":"110","author":"C Cerboni","year":"2007","unstructured":"Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood. 2007;110(2):606\u201315. https:\/\/doi.org\/10.1182\/blood-2006-10-052720.","journal-title":"Blood"},{"issue":"10","key":"2731_CR26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1084\/jem.186.10.1677.PMID:9362528;PMCID:PMC2199138","volume":"186","author":"B Zhang","year":"1997","unstructured":"Zhang B, Yamamura T, Kondo T, Fujiwara M, Tabira T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med. 1997;186(10):1677\u201387. https:\/\/doi.org\/10.1084\/jem.186.10.1677.PMID:9362528;PMCID:PMC2199138.","journal-title":"J Exp Med"},{"issue":"1","key":"2731_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1182\/blood.v99.1.61","volume":"99","author":"K Kogawa","year":"2002","unstructured":"Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002;99(1):61\u20136. https:\/\/doi.org\/10.1182\/blood.v99.1.61 PMID: 11756153.","journal-title":"Blood"},{"issue":"7533","key":"2731_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature13803","volume":"517","author":"D Liu","year":"2015","unstructured":"Liu D, Xu H, Shih C, Wan Z, Ma X, Ma W, Luo D, Qi H. T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction. Nature. 2015;517(7533):214\u20138. https:\/\/doi.org\/10.1038\/nature13803 Epub 2014 Oct 15 PMID: 25317561.","journal-title":"Nature"},{"issue":"9","key":"2731_CR29","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","volume":"21","author":"D Nehar-Belaid","year":"2020","unstructured":"Nehar-Belaid D, Hong S, Marches R, Chen G, Bolisetty M, Baisch J, Walters L, Punaro M, Rossi RJ, Chung CH, Huynh RP, Singh P, Flynn WF, Tabanor-Gayle JA, Kuchipudi N, Mejias A, Collet MA, Lucido AL, Palucka K, Robson P, Lakshminarayanan S, Ramilo O, Wright T, Pascual V, Banchereau JF. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol. 2020;21(9):1094\u2013106. https:\/\/doi.org\/10.1038\/s41590-020-0743-0.","journal-title":"Nat Immunol"},{"issue":"5","key":"2731_CR30","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.semarthrit.2020.06.004","volume":"50","author":"Q Yuan","year":"2020","unstructured":"Yuan Q, Xing X, Lu Z, Li X. Clinical characteristics and risk factors of infection in patients with systemic lupus erythematosus: A systematic review and meta-analysis of observational studies. Semin Arthritis Rheum. 2020;50(5):1022\u201339. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.004 Epub 2020 Jun 17 PMID: 32911280.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"2731_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11926-016-0561-4","volume":"18","author":"S Doaty","year":"2016","unstructured":"Doaty S, Agrawal H, Bauer E, Furst DE. Infection and Lupus: Which Causes Which? Curr Rheumatol Rep. 2016;18(3):13. https:\/\/doi.org\/10.1007\/s11926-016-0561-4 PMID: 26951251.","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"2731_CR32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3518","volume":"17","author":"C Guillerey","year":"2016","unstructured":"Guillerey C, Huntington ND, Smyth MJ. Targeting natural killer cells in cancer immunotherapy. Nat Immunol. 2016;17(9):1025\u201336. https:\/\/doi.org\/10.1038\/ni.3518 PMID: 27540992.","journal-title":"Nat Immunol"},{"issue":"532","key":"2731_CR33","doi-asserted-by":"publisher","first-page":"eaay1005","DOI":"10.1126\/scitranslmed.aay1005","volume":"12","author":"MR Mack","year":"2020","unstructured":"Mack MR, Brestoff JR, Berrien-Elliott MM, Trier AM, Yang TB, McCullen M, Collins PL, Niu H, Bodet ND, Wagner JA, Park E, Xu AZ, Wang F, Chibnall R, Council ML, Heffington C, Kreisel F, Margolis DJ, Sheinbein D, Lovato P, Vivier E, Cella M, Colonna M, Yokoyama WM, Oltz EM, Fehniger TA, Kim BS. Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. Sci Transl Med. 2020;12(532):eaay1005. https:\/\/doi.org\/10.1126\/scitranslmed.aay1005 PMID: 32102931; PMCID: PMC7433875.","journal-title":"Sci Transl Med."},{"issue":"15","key":"2731_CR34","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1073\/pnas.0601335103","volume":"103","author":"B Bielekova","year":"2006","unstructured":"Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci U S A. 2006;103(15):5941\u20136. https:\/\/doi.org\/10.1073\/pnas.0601335103 Epub 2006 Apr 3. PMID: 16585503; PMCID: PMC1458677.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"2731_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.645478.PMID:33828555;PMCID:PMC8019934","volume":"22","author":"M Humbel","year":"2021","unstructured":"Humbel M, Bellanger F, Fluder N, Horisberger A, Suffiotti M, Fenwick C, Ribi C, Comte D. Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE. Front Immunol. 2021;22(12): 645478. https:\/\/doi.org\/10.3389\/fimmu.2021.645478.PMID:33828555;PMCID:PMC8019934.","journal-title":"Front Immunol"},{"issue":"1","key":"2731_CR36","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","volume":"79","author":"J He","year":"2020","unstructured":"He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, Liu J, Zhang X, Zhang X, Jin Y, Wang Y, Zhang S, Zhu L, Jacob A, Jia R, You X, Li X, Li C, Zhou Y, Yang Y, Ye H, Liu Y, Su Y, Shen N, Alexander J, Guo J, Ambrus J, Lin X, Yu D, Sun X, Li Z. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2020;79(1):141\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215396 Epub 2019 Sep 19. PMID: 31537547; PMCID: PMC6937406.","journal-title":"Ann Rheum Dis."},{"key":"2731_CR37","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"2","author":"C Lood","year":"2016","unstructured":"Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, Malech HL, Ledbetter JA, Elkon KB, Kaplan MJ. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;2:146\u201353. https:\/\/doi.org\/10.1038\/nm.4027 Epub 2016 Jan 18. PMID: 26779811; PMCID: PMC4742415.","journal-title":"Nat Med."},{"issue":"9","key":"2731_CR38","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/art.34502.PMID:22549432;PMCID:PMC3411859","volume":"64","author":"ZW Lai","year":"2012","unstructured":"Lai ZW, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A, Miklossy G, Jimah J, Doherty E, Tily H, Francis L, Garcia R, Dawood M, Yu J, Ramos I, Coman I, Faraone SV, Phillips PE, Perl A. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012;64(9):2937\u201346. https:\/\/doi.org\/10.1002\/art.34502.PMID:22549432;PMCID:PMC3411859.","journal-title":"Arthritis Rheum"},{"key":"2731_CR39","doi-asserted-by":"publisher","unstructured":"He H, Wang C, Liu G, Ma H, Jiang M, Li P, Lu Q, Li L, Qi H. Isobavachalcone inhibits acute myeloid leukemia: Potential role for ROS-dependent mitochondrial apoptosis and differentiation. Phytother Res. 2021;35(6):3337\u201350. https:\/\/doi.org\/10.1002\/ptr.7054.\u00a0","DOI":"10.1002\/ptr.7054"},{"issue":"7","key":"2731_CR40","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.4049\/jimmunol.179.7.4513","volume":"179","author":"H Harlin","year":"2007","unstructured":"Harlin H, Hanson M, Johansson CC, Sakurai D, Poschke I, Norell H, Malmberg KJ, Kiessling R. The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset. J Immunol. 2007;179(7):4513\u20139. https:\/\/doi.org\/10.4049\/jimmunol.179.7.4513 PMID: 17878347.","journal-title":"J Immunol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02731-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02731-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02731-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T10:10:59Z","timestamp":1645006259000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02731-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2731"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02731-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the Declaration of Helsinki, and the design of the work was approved by the ethics committee of Affiliated Hospital of Nantong University and the ethics committee of the Dalian Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}